Rocket


News + Filings
Transactions


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Reardon Andrew Create: Alert

All | News | Filings
Date FiledTypeDescription
08/14/2023 4 Reardon Andrew (CHIEF LEGAL OFFICER &) has filed a Form 4 on LIGAND PHARMACEUTICALS INC
Txns: Paid exercise price by delivering 897 shares @ $68.73, valued at $61.7k
03/28/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/27/2023 4 Reardon Andrew (See Remarks) has filed a Form 4 on LIGAND PHARMACEUTICALS INC
Txns: Granted 5,668 shares @ $0
Granted 15,393 options to buy @ $75.09, valued at $1.2M
12/01/2022 4 Reardon Andrew (See Remarks) has filed a Form 4 on LIGAND PHARMACEUTICALS INC
Txns: Paid exercise price by delivering 1,073 shares @ $72.9, valued at $78.2k
11/07/2022 3 Reardon Andrew (See Remarks) has filed a Form 3 on LIGAND PHARMACEUTICALS INC

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy